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Osteoarthritis (OA) is one of the most commonly occurring forms of arthritis in the world today. It is a debilitating
chronic illness causing pain and immense discomfort to the affected individual. Significant research is currently
ongoing to understand its pathophysiology and develop successful treatment regimens based on this knowledge.
Animal models have played a key role in achieving this goal. Animal models currently used to study osteoarthritis
can be classified based on the etiology under investigation, primary osteoarthritis, and post-traumatic osteoarthritis,
to better clarify the relationship between these models and the pathogenesis of the disease. Non-invasive animal
models have shown significant promise in understanding early osteoarthritic changes. Imaging modalities play a
pivotal role in understanding the pathogenesis of OA and the correlation with pain. These imaging studies would
also allow in vivo surveillance of the disease as a function of time in the animal model. This review summarizes the
current understanding of the disease pathogenesis, invasive and non-invasive animal models, imaging modalities,
and pain assessment techniques in the animals.
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Osteoarthritis (OA) is a complex disease process involving
the whole synovial joint. It has the highest prevalence of
all forms of arthritis in the world and is the leading cause
of disability due to pain [1]. The most commonly affected
joint is the knee, and OA has a higher occurrence in older
adults particularly women [1–4]. In the USA alone, nearly
27 million adults were estimated to have the disease
in 2008 [3]. This figure along with our limited know-
ledge of OA pathogenesis necessitates the need for
significant research efforts to better understand the
disease development and progression. These insights
could subsequently lead to the development of successful
treatment regimens.* Correspondence: laurencin@uchc.edu
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portant to define the “disease” and “illness” states of OA
[5]. The “disease” of OA is defined as the measurable ab-
normalities which could lead to the illness. The disease
could be metabolic and molecular derangements trigger-
ing anatomical and/or physiological changes in the joint.
These characteristic changes are found radiographically
as joint space narrowing, subchondral sclerosis, sub-
chondral cysts, and osteophyte formation. The “illness”
of OA is defined as the symptoms which bring the pa-
tient to the hospital. The associated symptoms could be
pain or immobility. Because patients generally present in
the clinic after these symptoms of the illness develop,
most treatment techniques for OA are designed to ad-
dress these symptoms rather than cure the underlying
disease. This is why research into the early development
of OA has been on the increase to study and treat the
disease in its early stages. Current conservative treat-
ments include lifestyle modification and pain medication
(such as NSAIDs and duloxetine) which predominantly
treat the illness (e.g., pain symptoms) [6, 7]. There is alsois distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
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to decrease joint space narrowing in OA, thus treating
the disease itself [8, 9]. Conversely, surgical intervention
(partial or total joint replacement) is the preferred treat-
ment method in end-stage (severe) disease leading to
some relief of both the illness and disease [6].
The current information we have on OA comes from
both clinical and preclinical studies. These have proven
to be invaluable tools to characterize the development of
osteoarthritis. However, human clinical studies present
several limitations. Variations between the onset of the
symptoms and the disease in humans make it difficult to
accurately study the disease [10]. The chronic nature of
the disease combined with the significant variability in
the rate of disease progression in human subjects also
presents challenges [10, 11]. Without preclinical models,
these impediments in clinical trials would have
prevented current medical advances in learning about
and treating the disease. The in vivo preclinical animal
models have been employed to accomplish two main
goals (1) to study the pathogenesis of the disease and
(2) to study the therapeutic efficacy of treatmentFig. 1 Signaling pathways and structural changes in the development of o
diseased joint (b). ADAMTS a disintegrin and metalloproteinase with throm
tumor necrosis factor, IFN interferon, IGF insulin-like growth factor, TGF tran
with permission from Glyn-Jones et al. [33]modalities [12, 13]. While there are known similarities
in the disease process between animals and humans,
just one animal model is not sufficient to study all fea-
tures of OA. The translatability of the results of each
model to the human clinical condition varies [14–17].
As such, several models have been developed and reported
extensively in the literature to study various features of the
disease. The usefulness of each model, histopathological
outcome studies, and relationship of the models to human
pathogenesis have been reviewed elsewhere [12, 16, 18, 19].
This review serves to classify the disease, the correspond-
ing animal models and their uniqueness, as well as
summarize the literature on OA pathogenesis (Fig. 1) and
measures of disease outcomes.
Osteoarthritis pathogenesis
OA was originally believed to be caused by the wear and
tear of the articular surfaces in the joint. Our current
understanding points to a far more complex mechanism.
However, these findings in OA pathogenesis may only
represent post-traumatic osteoarthritis (PTOA) [20–22].
Although there are a lot of differing opinions on thesteoarthritis with showing the normal joint (a) and showing the
bospondin-like motifs, I interleukin, MMP matrix metalloproteinase, TNF
sforming growth factor, VEGF vascular endothelial growth factor; taken
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summarizes the most commonly held beliefs on OA
development and progression.
OA involves the degeneration of cartilage, abnormal
bone remodeling, osteophyte formation and joint inflam-
mation [5]. Four components of the synovial joint par-
ticipate in this pathology. These are the meniscus
(majority of synovial joints), articular cartilage, subchon-
dral bone, and synovial membrane (Fig. 1a). In the
healthy joint, these components provide support to the
joint. The meniscus (not shown in Fig. 1a) provides sev-
eral functions including load bearing and shock absorp-
tion in the knee joint. It is a fibrocartilage composed
mainly of water, type I collagen, and proteoglycans (pre-
dominantly aggrecan) in its extracellular matrix [23, 24].
Other components include type II, III, V, and VI colla-
gen. The articular cartilage provides a surface for move-
ment of the synovial joint. It is a hyaline cartilage
composed mainly of proteoglycans and type II collagen
in the matrix. It is divided into deep, middle, and super-
ficial zones characterized by the differences in the matrix
composition and cell orientation [25, 26]. Calcified car-
tilage serves as an interface between the bone and ar-
ticular cartilage (Fig. 1a). The subchondral bone gives
support to the joint and is composed of mineralized type
I collagen. The synovial membrane (synovium) produces
the synovial fluid. This fluid, which is composed of lubri-
cin and hyaluronic acid, lubricates the joint and nour-
ishes the articular cartilage [27–31]. The synovium is
composed of two types of synoviocytes: fibroblasts
and macrophages [27, 28, 31]. The synovial fibroblasts
produce the synovial fluid components. The synovial
macrophages are usually dormant but are activated
during inflammation.
Several abnormalities in the normal function of these
components have been found to promote OA in the
joint (Fig. 1b). Mechanical abrasion in the knee can lead
to the progressive degenerative changes in the meniscus
with loss of both type I and, more severely, type II colla-
gen [20, 32]. This effect initially occurs from the mid-
substance of each meniscus rather than the articulating
surface. More importantly, recent studies point to an in-
flammatory mechanism for the initial stages of the dis-
ease. This occurs mainly in response to injury caused by
mechanical stimulation of the joint. The release of cyto-
kines, such as interleukin-1 (IL-1), IL-4, IL-9, IL-13, and
TNF-α, degradative enzymes such as a disintegrin and me-
talloproteinase thrombospondin-like motifs (ADAMTS),
and collagenases/matrix metalloproteinases (MMPs) by
chondrocytes, osteoblasts, and synoviocytes triggers the
process (Fig. 1) [20, 33, 34]. Furthermore, the innate
immune system plays a role in OA progression through
the activation of both the complement and alternative
pathways [35].The released MMPs cause collagen matrix degrad-
ation, leading to the degradation of articular cartilage
[36]. Under this condition, the chondrocytes undergo
hypertrophy, losing the ability to form new cartilage
matrix [34]. The subchondral bone undergoes abnormal
remodeling and invades past the interface between the
bone and calcified cartilage (Fig. 1b). This leads to the
formation of subchondral cysts and osteophytes [33].
The osteophytes formed serve to correct the joint in-
stability caused by the disease. Subchondral sclerosis is
yet another result of this abnormal bone remodeling, but
this may either occur late in the disease process [37] or
become a cause of osteoarthritic changes [38]. Addition-
ally, the release of vascular endothelial growth factor
(VEGF) by chondrocytes may lead to the vascularization
of the synovium and vascular invasion of the joint [34].
VEGF release is due to the prolonged mechanical load-
ing on the articular cartilage [39, 40]. This release can be
worsened in cases of varus and valgus knee joint mala-
lignment where there is increased mechanical loading
on the tibiofemoral joint of the medial or lateral knee
compartment, respectively [41]. This loading has been
associated with subchondral bone marrow lesions which
are visible on magnetic resonance imaging (MRI) and
have been associated with pain [42]. Pain may originate
from the remodeling of the subchondral bone due to its
rich innervation [33]. Pain may also occur from the ini-
tial inflammation of the synovial membrane (synovitis)
in this disease. This membrane progressively becomes fi-
brotic over time [33, 34]. Moreover, peripheral neuronal
sensitization and central sensitization could play a part
in the pain of osteoarthritis, providing possible targets
for drug therapy [43, 44].
Other factors may contribute to OA pathogenesis in
the cartilage. In aging individuals, chondrocytes increase
their production of inflammatory cytokines. Advanced
glycation end products (AGE; Table 1) have also been
implicated in this process. These AGEs accumulate in
the articular cartilage in older individuals. They bind to
receptors on chondrocytes leading to the release of pro-
inflammatory cytokines and VEGF, ultimately leading to
cartilage degeneration [45–47]. This pathway illustrates
the influence of age in the development of OA and en-
dorses a sequence of natural disease occurrence. Adipo-
kines, cytokines secreted by adipose tissue and the
infrapatellar fat pad in the knee, have been linked with
the degradation of articular cartilage. This implies the
potential role of obesity, in the development of OA
[48–50]. Importantly, systemic inflammation has been
posited as an additional pathologic feature of OA. Al-
though many studies question if it plays a role in the dis-
ease process, due to the belief that OA is a focal disease,
quite a few published works in recent years indicate that
OA should be classified as a systemic musculoskeletal
Table 1 Proposal for differentiation of clinical phenotypes of OA
Post-traumatic
(acute or repetitive)
Metabolic Aging Genetic Pain
Age Young (<45 years) Middle-aged (45–65 years) Old (>65 years) Variable Variable
Main causative
feature





Gene related Inflammation, bony
changes, aberrant
pain perception
Main site Knee, thumb, ankle,
shoulder
Knee, hand, generalized Hip, knee, hand Hand, hip,
spine
Hip, knee, hand















Osteoarthritis is not one disease and might benefit from the recognition of its different phenotypes. Adapted with permission from Bijlsma et al. [6]
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niscus damage in OA with simultaneous hand osteoarth-
ritis incidence supports a systemic/genetic susceptibility
to OA [32].
The current findings on OA pathogenesis present cy-
tokines and inflammation as possible targets of treat-
ment. These could warrant the use of drugs against pro-
inflammatory cytokines, such as anti-rheumatic drugs, in
the treatment of the disease. These drugs have shown
varying success in preclinical studies; however, they have
not been fully tested in clinical studies [35]. In addition
to these, lifestyle modifications and other treatment
methods may play important roles in the treatment and
prevention of the disease [48].
Common animal models used for OA
For animal models of OA, the stifle (knee) is the joint
regularly used. Other joints studied include the metacar-
pophalangeal and middle carpal joints of the horse [51]
and the temporomandibular joint (TMJ) in STR/ort mice
[52] and discoidin domain receptor 1 (DDR1) knockout
mice [53]. There are well-published studies on the ap-
plication of the metacarpophalangeal joint in the
horse model, and this joint has great similarities to the
human knee joint [16, 51].
Both small and large animals have been used to de-
velop OA models. Small animal models include the
mouse, rat, rabbit, and guinea pig. Large animal models
include the dog, goat/sheep, and horse. The choice of
each animal to be used depends on several factors in-
cluding, but not limited to, the type of experiment/study,
length of time, husbandry costs, ease of handling, and
outcome measurements. The length of time needed to
complete the experiment depends on the skeletal matur-
ation of each animal [54]. This is the time taken for each
animal to reach skeletal maturity and, as a consequence,
develop OA. Each animal has its relative advantage
over the other. Some represent the best models to
study each disease process and this will be discussed
later in this review.Small animal models are mainly used to study the
pathogenesis and pathophysiology of the disease process.
These models are relatively quicker, cheaper, and easier
models to implement and study than the large animal
models. They are used as the first screening model for
therapeutic intervention in the disease. Success of the
drugs or treatment in the small animal model then war-
rants further testing in larger animals before clinical stud-
ies in humans. However, the drugs, though shown to be
efficacious in small animal studies, may not be translatable
to human with equal efficacy [17]. A reason for this could
be the great difference between the anatomy, histology,
and physiology of these animals and humans. For ex-
ample, the average cartilage thickness in mice is at least 70
times smaller than that in humans [16].
Large animal models are also used to study the disease
process and treatment. Their anatomy is markedly
similar to that of humans. For instance, the cartilage
thickness of dogs is less than half the size of humans.
This striking similarity is why studies of cartilage de-
generation and osteochondral defects are much more
useful in large animal models. These models should
be used to confirm the efficacy of drugs before clin-
ical trials [16, 17].
Non-human primates such as baboons, rhesus ma-
caque, and cynomolgus macaque present a special case
for studying naturally occurring (primary) OA. These
animals share several biological and behavioral similar-
ities to humans. The development of OA in these ani-
mals follows a comparable development to humans,
making them useful for OA research [55–63]. However,
these similarities have also been given as reasons for
their exclusion from research [64]. For instance, chim-
panzees used in experiments exhibit depression and
post-traumatic stress disorder similar to the human
equivalent [65]. These ethical issues in conjunction with
the high costs of care are huge obstacles to their wide-
spread application [16, 66]. The years to completion of
these studies serve as an additional obstacle to their use,
as non-human primates have a long lifespan. For
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to skeletal maturity being 8 years [56, 67].
Classification of osteoarthritis and animal models
OA has typically been classified into primary (idiopathic)
and secondary OA [68–70] (Fig. 2) based on the disease
etiology. Primary osteoarthritis (POA) is a naturally oc-
curring phenomenon due to degenerative changes in the
joint. It is further classified into localized and general-
ized OA. Localized OA affects one joint while general-
ized OA affects three or more joints. Secondary OA is
normally associated with causes and/or risk factors lead-
ing to OA in the joint. These include trauma, congenital
diseases, and other diseases or disorders of metabolism
or the bone [68, 69]. It is important to note that the
heterogeneous nature of OA presents challenges to its
classification and treatment. For that reason, one treat-
ment cannot apply to all patients with the disease [10, 33].
The variability of etiology, treatment, and outcomes for
each patient makes the need to classify OA into clinical
phenotypes a highly discussed venture [6, 33, 71, 72].
These discussions propose that categorizing OA into clin-
ical phenotypes, adapted to their specific treatment, will
improve patient outcomes. Based on these recommenda-
tions, five phenotypes have been proposed (see Table 1)
which replace the original primary and secondary
classifications with features of the disease [6]. TheseFig. 2 Classification of osteoarthritis models based on etiology in human e
red box represents the original classification of in vivo osteoarthritis models
Black arrows represent the type of models used. Both non-invasive canine
osteoarthritis, IATPF intra-articular tibial plateau fracture, CACTC cyclic articulinclude post-traumatic, metabolic, aging, genetic, and
pain phenotypes.
The post-traumatic OA phenotype is analogous to
post-traumatic osteoarthritis (PTOA), which is caused
by acute or repetitive injury to the joint (Table 1). Pa-
tients with this phenotype would benefit from preventa-
tive measures, such as the use of braces in athletes,
prevention from falls in older adults, and prevention of
surgical intervention such as meniscectomies. The meta-
bolic/obesity phenotype represents both the effect of in-
creased loading on weight-bearing joints from obesity
and the role of adipokines on the development of OA.
Understanding this phenotype would help in therapy de-
cisions such as exercise programs for weight loss goals
and hormone therapy for menopause-related OA. The
aging phenotype is most analogous to POA. It is a natur-
ally occurring phenotype due to advanced aging of the
individual. This phenotype could benefit from targeted
therapy designed to inhibit AGEs and the cytokines re-
leased from senescent chondrocytes (Table 1). The genetic
phenotype is related to how hereditary factors affect the de-
velopment of OA through complex mechanisms [73–75].
These findings could provide specific targets for gene or
drug therapy [76]. Finally, the pain phenotype describes the
development of OA pain due to inflammation and abnor-
mal bone remodeling in the joint [43, 77]. The development
of anti-inflammatory and pain medications would benefitquivalent being studied, primary OA and post-traumatic OA. Dashed
. Blue arrows indicate the models used to replicate the disease etiology.
and lapine models involve the use of transarticular impact. OA
ar cartilage tibial compression
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types have been described [78–82], this proposal serves as
the closest classification to understand the pathogenesis of
the disease and its correlation to the animal models. These
five phenotypes may also prompt increased discussion of
the disease as we make new discoveries on its
pathophysiology.
Osteoarthritis models have classically been categorized
into spontaneous and induced models. For simplicity,
the models have been grouped here into two basic clas-
ses of OA (Fig. 2). These will be primary osteoarthritis
(POA) and PTOA which is a subcategory of secondary
OA. These models and their subdivisions share a relation-
ship with OA phenotypes (Table 1 and Fig. 2). The post-
traumatic phenotype can be studied by post-traumatic OA
models. The metabolic phenotype can be studied by surgi-
cal and naturally occurring animal models tailored to
study the effect of obesity and other metabolic causes of
OA such as diabetes and estrogen imbalance [83–88].
Spontaneous OA models would provide the best models
to study the aging phenotype as they represent POA
(Fig. 2). The genetic phenotype has been explored using
rat models of anterior (cranial) cruciate ligament (ACL)
transection and medial meniscectomy using gene expres-
sion analysis [89]. In addition, other studies using small
and large animal models exist in the literature to find tar-
gets for drug or gene therapy [76, 90, 91]. Lastly, pain phe-
notypes can be studied using pain models of OA. They
show considerable overlap with PTOA models. We will
discuss these models in the following sections.
Primary osteoarthritis: spontaneous models
Spontaneous models are the hallmark of primary osteo-
arthritis (Fig. 2). The occurrence of slowly progressing
OA in certain animals (mouse, guinea pig, dog, rabbit,
and horse) closely simulates the natural progression of
human primary osteoarthritis and are commonly used as
naturally occurring OA models [12, 13, 16]. In addition
to this, various transgenic mouse models (genetically
modified models) have been designed which have the
ability to develop OA without intervention. Spontaneous
models rely on these pathological changes rather than
post-traumatic alterations. Animals used in spontaneous
models can also be used to study induced (surgical)
osteoarthritic changes. Moreover, these animal models
serve as a platform to compare spontaneous and in-
duced osteoarthritis. Since these animals develop OA
much more rapidly and extensively than other surgically
induced models, spontaneous OA can be observed to
develop in one joint and induced osteoarthritis created
in the contralateral joint in these animals for direct com-
parison [21, 92, 93].
A major drawback of spontaneous models is the time
required for the injury to develop. Each animal has to befollowed to maturity before OA develops. For example,
the Dunkin Hartley guinea pig usually develops OA
3 months after birth but reaches skeletal maturity at
6 months [93–95]. This lengthy experimental time
makes it difficult to conduct short-term studies. Yet, this
ensures that the results closely mimic the slow progres-
sive changes noted in human POA [12]. Another disad-
vantage is the cost of this study. The cost of housing
increases as these animals have to be followed over a
prolonged period of time.
Naturally occurring models
Mice, rabbits, guinea pigs dogs, sheep, and horses ex-
hibit naturally occurring OA. The Dunkin Hartley
guinea pig has been the most widely used animal to
study naturally occurring OA [12, 93, 96]. These animal
models give the best representation of POA in humans.
One advantage they have over larger animal models is
their rapidity of growth to maturity [95]. Another advan-
tage is that they develop lesions markedly similar to hu-
man subjects, furthering the possibility of their use in
therapeutic and pathogenic studies [93]. The guinea pig
is also a great natural model to study inflammation in
the joint [97].
STR/ort mice are strong examples of mice exhibiting
naturally occurring OA and can be used to study the
disease pathogenesis [98]. For example, the STR/ort
mouse model was used to show a correlation between
OA and chondrocyte metabolism [99, 100]. Rabbits have
also served as good models to study the disease. This
species may help aid the development of bioengineered
treatment of cartilage defects [101, 102]. Dogs have been
beneficial as natural models in preclinical trials of thera-
peutic intervention [103–105].
The horse articular cartilage is the most comparable to
humans. They have been used to study articular cartilage
repair and osteochondral defects [16, 106, 107]. This
animal provides a naturally occurring model to study
bone remodeling, which leads to bone cysts and osteo-
phyte formation [108, 109]. This could aid the develop-
ment of treatment to combat these changes in humans,
especially in POA. The sheep model has been successful
in studying early cartilage changes in OA [110]. Due to
their anatomical similarity to humans, this model can be
used to study meniscus changes and related treatment
techniques [110–112].
Genetically modified models
The major advantage of mouse models in OA studies is
the ability to genetically modify them or breed specific
strains particularly susceptible to OA. Therefore, trans-
genic mice have been used extensively as genetically
modified species to study OA. The gene mutations in
these animals are designed to either protect the animal
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[21]. Consequently, these studies have helped to establish
the molecular basis of OA including the effect of pro-
inflammatory cytokines on OA development [21, 113].
For example, knockout mice lacking a particular protease
could be resistant to developing OA [114]. Another ex-
ample is mice with collagen type IX alpha 1 gene inactiva-
tion, also called Col9a1 (−/−), which have been used to
characterize the role of collagen type IX in osteoarthritis
[115–117]. Genetically modified models have played a
crucial role in understanding specific genetic contribu-
tions to the pathogenesis of OA [18, 114]. However, thera-
peutic interventions targeting these specific genes do not
take into account other contributing genes that participate
in the pathogenesis of the disease [16]. This may reduce
the translatability of results to clinical trials.
Secondary OA
As mentioned earlier, secondary OA is a condition
occurring in the presence of specific causes or risk
factors. Although these causes include congenital, calcium
deposition, bone, joint (e.g., rheumatoid arthritis), and
metabolic disorders, PTOA is the most widely studied.
This is especially true in animal models [21]. PTOA oc-
curs due to an insult/injury to the affected joint. It can be
studied by two OA models which are caused by a direct/
indirect injury to the joint: induced (invasive) models and
non-invasive models of osteoarthritis. Due to its advan-
tages, the last few years have seen significant interest in
developing a number of non-invasive models in mice,
dogs, and rabbits. These could serve as viable alternatives
to induced models of OA. The next few sections discuss
the differences between the invasive and non-invasive
models to study PTOA.
Post-traumatic osteoarthritis: induced/invasive models
Induced (invasive) models have been used to study the
effect of drugs on the disease process. They can further
be classified into surgically induced and chemically in-
duced models. The rapid induction of osteoarthritis by
these models ensures that the study can be performed in
a shorter time frame. Yet, a weakness of induced models
is that they have no correlation to natural degenerative
changes in human degenerative osteoarthritis [12]. How-
ever, surgically induced models have been used to study
the pathogenesis of post-traumatic osteoarthritis, an ex-
ample being subchondral bone changes [118].
Surgically induced models A large number of surgi-
cally induced OA models exist in the literature. Com-
monly used models include anterior cruciate ligament
transection (ACLT; most common), meniscectomy (par-
tial and total), medial meniscal tear, and ovariectomy.
Surgical models involve the use of aseptic techniques tosurgically induce OA in animals. The results are highly
reproducible and progress rapidly. This makes surgical
models an excellent choice for short-term studies. Yet,
this invasive rapid induction may be too quick in order
to follow the early stages in OA development as well as
for measuring early drug treatment.
The ACLT model was the earliest well-known model
and is the most commonly used surgical model in OA
research today [12, 16]. The rationale for using this
model is that ACL injury causes joint destabilization
which subsequently leads to PTOA. The model imitates
the degradation of articular cartilage after ACL rupture.
Compared to meniscectomy, the OA lesions in ACLT
develop more slowly, increasing the ease of use of this
model in pharmaceutical studies [119]. The anterior
drawer test is used to test the success of this procedure
[12]. Although it has been used extensively in several
animals, the sheep/goat is the best animal group ana-
tomically for this model. The stifle in these animals is
large enough for easy replication of the procedure.
The goat in particular has the closest anatomy to the
human knee [110].
In animals, as in humans, meniscectomies lead to
osteoarthritic changes in the joint [120, 121]. A partial
meniscectomy causes a destabilization of the joint lead-
ing to rapid degeneration and a more severe case of
osteoarthritis than ACL transection [122]. The site for
the surgical procedure, medial or lateral, varies by ani-
mal model. This is due to the differences in load bearing
of each animal on its menisci. For example, humans, as
with guinea pigs, usually load the medial side of the
knee. This may vary based on the varus or valgus align-
ment of the knee leading to medial or lateral osteoarth-
ritis, respectively [41]. In contrast, rabbits load their
lateral meniscus more than their medial [13]. This is
why rabbits develop more severe lateral osteoarthritis
when surgery is performed on that meniscus. Just as
partial meniscectomies, total meniscectomies follow a
similar mechanism of injury. Nevertheless, this model
leads to much more severe osteoarthritic changes in
animals. Dogs are the most widely used animals for
this procedure mainly due to the volume of literature
on their application.
Alternatively, medial meniscal tear in humans causes
joint instability and cartilage degradation. The medial
meniscal tear model in animals is achieved through
transection of the medial collateral ligament in the
knee [13, 16]. It causes proteoglycan and chondrocyte loss
leading to cartilage degradation. Rats and guinea pigs are
the most studied examples of animals using this model.
The recommended study period for rats is at least after
3 weeks post-surgery. The advantage of guinea pigs in the
study is the ability to compare the contralateral joint for
natural osteoarthritic changes [13].
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that post-menopausal individuals develop osteoporosis,
consequently leading to OA. Thus, estrogen serves a
protective function to the development of OA [123].
New Zealand rabbits have been recommended to study
the direct effect of estrogen deficiency to the develop-
ment of OA [87, 88, 124]. Other animals include mice,
rats, guinea pigs, and sheep [125–130]. Although this
model can be used to study therapeutic intervention
[124], it is believed that this model would be more useful
in determining other pathological pathways to the devel-
opment of OA due to its unknown pathophysiology [12].
Chemically induced models Chemically induced
models mostly involve the injection of a toxic or inflam-
matory compound directly into the knee joint. This
model can be used to study the effects of drugs on the in-
flammation or pain caused by these substances. Papain,
sodium monoiodoacetate, quinolone, and collagenase are
some of the chemicals employed to induce OA in animals.
They eliminate the need for surgery and avoid possible in-
fection issues in some animals. Their ease of induction
and reproducibility are advantageous in designing short-
term studies. Although less invasive than surgical models,
chemical models have a unique pathophysiology which
has no correlation to that of post-traumatic OA. This ex-
plains why they are mainly used to study the mechanism
of pain and its use as a target for drug therapy [12].
Papain is a proteolytic enzyme which was historically
used in OA induction. It breaks down proteoglycans, im-
portant components of cartilage that give it compressive
resistance through the absorption of water [33]. How-
ever, the use of papain for an OA model is becoming in-
creasingly rare. Instead, the most commonly used
compound in OA study today is sodium monoiodoace-
tate (MIA) [131]. It inhibits glyceraldehyde-3-phosphate
dehydrogenase of the Krebs cycle leading to the death of
chondrocytes. This in turn causes osteophyte formation
and articular cartilage degradation [132]. The result is
rapid inflammation and pain which lasts for 7 days,
then chronic musculoskeletal pain starting at the 10th
day post-injection. MIA-induced OA model is regularly
used to measure pain behavior and drug therapy to re-
solve the pain in animals. This model may be more pre-
dictive of drug efficacy than other pain models used to
test OA drugs [133]. It is generally used in mice and
rats [134].
Other toxic compounds such as quinolones and colla-
genase have been used. Oral quinolone antibiotics usu-
ally cause growth defects in young children. This occurs
through their action on the epiphyseal growth plate of
their bones. It can also cause loss of proteoglycans and
chondrocytes through systemic administration [12, 135].
This mechanism serves the use of this antibiotic incausing lesions in animals, though it does not cause
osteophyte formation [113]. As mentioned previously,
the release of collagenase in OA leads to the degradation
of proteins in the articular cartilage. As a chemically in-
duced model, intra-articular administration of collagenase
breaks down type I collagen within the cartilage leading to
decreased collagen matrix in the tendons and ligaments,
consequently leading to joint instability [113, 136]. This
makes it an excellent model to study pain behavior corre-
sponding to osteoarthritic changes [137].
Post-traumatic osteoarthritis: non-invasive animal models
For several decades, the study of PTOA has involved the
use of induced/invasive models. However, the proce-
dures of these models require the use of aseptic tech-
niques to avoid infection (Table 3) [12]. Inflammatory
changes caused by infection would affect the results of
the experiment. The success of these models also de-
pends on the ability of the surgeon/investigator to con-
sistently reproduce the surgery on all animals of the
study. Some of these shortcomings can be resolved with
non-invasive models. These models produce an external
insult to the joint of study, negating the need of any
chemical or surgical intervention. They are powered by
machines which cause injury through mechanical im-
pact, without causing a break in the skin of the animal.
This injury causes osteoarthritic changes similar to in-
duced animal models in the animal being studied. A not-
able advantage is that the injury can be created with
precision, which is not always feasible in the more inva-
sive models [4]. Given that PTOA usually occurs after
external joint trauma to young human adults, the bio-
mechanics of the human injury that lead to PTOA can
be replicated. Table 2 summarizes some of the differ-
ences between each non-invasive model, and Table 3
summarizes the advantages of the non-invasive models
over the invasive/induced models.
Mouse models The theory behind the invention of non-
invasive mouse models is that confounding factors,
which may affect the results of induced OA models, can
be eliminated while reproducing human traumatic injur-
ies in animals [4, 138]. Some of these factors include the
expertise of the surgeon and the effect of the surgery or
wound on the results of the experiment (Table 3). More-
over, the early phases of OA can be studied using these
models. Thus, the knowledge generated by these models
could become essential in developing early therapeutic
intervention for PTOA [139].
Outcome measures for these mouse models have in-
cluded micro-computed tomography (μ-CT) scans for a
visual representation of the fracture and Safranin-O
staining for proteoglycan content, both to follow the
pathology of osteoarthritis [4, 140]. With proteoglycans
Table 2 List of non-invasive OA models listing their uses, advantages, and disadvantages
Model Usefulness and advantages Disadvantages
IATPF Reproduces PTOA from high energy impact Not useful for chronic injuries
Used to study early OA changes after acute injuries or
fractures
Not useful for low energy impact
Severity of lesions can be adjusted
CACTC Reproduces chronic joint overuse Not useful for acute injuries
Used to study early OA changes after chronic overuse injury Several cycles and weeks needed to cause severe changes
Tibial compression
overload
Reproduces PTOA from low energy impact Not useful for long-term studies
Used to study severe early OA changes after acute injuries Cannot use contralateral limb as control in long-term
studies
One single load needed
Transarticular Impact Reproduces PTOA Cannot use contralateral limb as control in long-term studies
Severity can be adjusted
Potential to study surgical knee replacement
Readily available non-invasive studies
IATPF intra-articular tibial plateau fracture, CACTC cyclic articular cartilage tibial compression, PTOA post-traumatic osteoarthritis, OA osteoarthritis
Kuyinu et al. Journal of Orthopaedic Surgery and Research  (2016) 11:19 Page 9 of 27such as aggrecan being a major component in cartilage,
continuous loss of Safranin-O staining is indicative of pro-
teoglycan loss, thus loss of cartilage. The possible use of
in vivo fluorescence reflectance imaging (FRI) to quantify
inflammation in PTOA has been proposed [141].
Three major mouse models for non-invasive OA have
been described (Fig. 2) [4]: (1) intra-articular tibial plat-
eau fracture; (2) cyclic articular cartilage tibial compres-
sion; and (3) anterior cruciate ligament (ACL) rupture
via tibial compression overload.
Intra-articular tibial plateau fracture
The earliest of the non-invasive mouse models is the
intra-articular tibial plateau fracture (IATPF; see Fig. 3a)
[142]. In this model, the flexed knee of the anesthetized
mouse is fixed on a triangular cradle while an indenter
provides the force of impact. The indenter causes a
closed fracture of the joint, and the severity of changes
can be varied by adjusting the amount of force applied.
These fractures could replicate acute trauma in the hu-
man condition from high energy impacts (such as a
front end motor vehicle accident [4]). The intra-articularTable 3 Pros and cons of invasive versus non-invasive animal mode
Induced/invasive Non
Similar pros Rapid induction (except CACTC)
Easily reproducible
Individual Pros Materials readily available Min
Multiple studies in the literature present Use
Cons Possibility of infection Equ
Relies on expertise of surgeon Reli
Induction too rapid to study early changes or
early drug therapy
Min
CACTC cyclic articular cartilage tibial compression, OA Osteoarthritistibial plateau fracture (IATPF) can also follow the early
effects of inflammation in OA [143]. Intra-articular frac-
tures are a known cause of PTOA, and there is a need
for studies to better aid the prevention, treatment, and
understanding of the disease [143–146]. Therefore, this
serves as an ideal model to study the pathogenic changes
that occur in joint degeneration after acute injury.
Cyclic articular cartilage tibial compression
In this model, an axial load is applied to the stifle lead-
ing to an anterior displacement of the tibia relative to
the femur (See Fig. 3b) [140, 147, 148]. The load could
be applied in cycles over a period of time or as a one-
time single overload if the goal is to cause an ACL rup-
ture. The long-term effects of injury can be studied, by
applying several cycles over a period of time and by
adjusting the load on the joint to be studied. With re-
petitive compressions over a period of time, this model
could be used to study subchondral bone changes. How-
ever, the contralateral limb cannot be used as a control
with a longer loading period of the ipsilateral limb [149].
Increased bone remodeling and increased osteophytesls of OA
-invasive
imal infection risk
d to study early changes and the effects of early therapeutic intervention
ipment not universally available
es on proficiency of technician/investigator
imal literature on application
Fig. 3 a Non-invasive mouse models of osteoarthritis: line drawing of IATPF showing the mouse knee flexed on the cradle and indenter applying
force. This causes a closed fracture of the tibial plateau. b Non-invasive mouse models of osteoarthritis: diagrammatic representation of cyclic
articular cartilage tibial compression on the flexed right hind limb of the mouse. This model can also cause an ACL rupture at higher loads. The
direction of the load between the upper and lower loading cups is shown. Location of strain gauges ion the apparatus (a, lateral and b, medial)
on the tibial mid-shaft are also shown. IAPF intra-articular tibial plateau fracture, ACL anterior cruciate ligament. Taken with permission from Furman et al.
[142] and Souza et al. [147]
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age degeneration is seen with a higher load (9 N) in this
mouse model [153]. Thus, cyclic articular cartilage tibial
compression (CACTC) is the preferred model to study
the effect of chronic overuse injury on the development
of OA.
Tibial compression overload
As with CACTC, this model relies on a similar mech-
anism of anterior subluxation of the tibia to produce in-
jury (Fig. 3b). One problem with the CACTC is that
multiple cycles over a long period of time are needed to
induce severe symptoms of OA. A quicker way to induce
immediate and severe injury, with subsequent osteoarth-
ritic changes, is by applying a single cycle with a load of
12 N and a speed of 500 mm/s in a similar model [138,
150, 154]. This tibial compression overload leads to a
mid-substance rupture of the ACL. ACL ruptures due to
cyclic tibial compression produce comparable injury
pathology to human ACL rupture. The injury pathology
generated is also analogous to the animal ACL transec-
tion model but without the need of invasive surgery. If
the load and speed are strong enough, the result is either
a mid-substance rupture of the ACL or, at lower
loads or speeds, an avulsion fracture of the ACL
from the underlying bone [150]. This model is ideally
suited to study early osteoarthritic changes and the
effect of early treatment following acute low energy
impacts, such as a sports injury to the knee [151, 155].
This serves as a significant advantage over the IATPF
model, which replicates high energy impacts. How-
ever, long-term studies cannot be accomplished dueto bone osteophytic changes which serve to stabilize
the joint [150].
Future direction: non-invasive rat models
The application of cyclic tibial compression in rats has
recently been examined [156]. This experiment, the first
of its kind, included the use of motion capture and
quantitative joint laxity testing. The hind limb knee of
euthanized rats were flexed at 100° and mechanically
compressed. The model causes an ACL rupture with a
minimum displacement of 3 mm and a minimum com-
pressive speed of 8 mm/s. Laxity of the lateral collateral
ligament (LCL) also occurred in this experiment. It ex-
pedites the successful application of non-invasive models
in rats. Similary, this could encourage the use of the tib-
ial compression model in larger animals. One advantage
of a larger animal model over the corresponding mouse
model is the possible use of in vivo magnetic resonance
imaging (MRI) to observe osteoarthritic changes
throughout the study [16]. Another advantage is that it
may generate a closer approximation of drug efficacy in
PTOA studies. However, the effects of genetics on the
development of PTOA can be readily studied in genetic-
ally modified rodents and not in larger animals [142].
Canine models In the last two decades, various non-
invasive canine models have been developed to investigate
various aspects of OA [157–159]. Potential therapeutic
options are currently under development using these
models. Although several breeds such as the Labrador,
golden retriever, and German shepherd have been
used in canine models, the beagle dog is the
Fig. 4 a Positioning of the beagle dog in the apparatus that was used for the application of the transarticular load. The right lower limb is held
rigidly with the animal lying in lateral recumbency. Adapted with permission from Lahm et al. [157]. b Schematic representation of the experimental
setup from fluoroscopy. Note the dropping tower used to apply the load on the patellofemoral joint
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Transarticular impact involves the use of a dropping
tower to cause an impact on the patellofemoral joint
of the immobile knee (See Fig. 4), without breaking
the skin. A load of approximately 2000 N is applied
to cause the desired changes. Subsequently, canine
models have been used to test the early changes of
osteoarthritis that occur in articular cartilage due to
joint impact trauma [12, 158]. They were specifically
designed to study these changes and could be used to
produce osteochondral lesions with higher loads [157,
159]. In one study, this model illustrated that the
high impact on these joints without fracture will lead
to healing within a year of injury [160]. This is despite
early MRI images showing adverse changes following the
impact. Biopsies served as the histological specimens in
these studies, negating the need for euthanasia to harvest
tissue samples. This model has the capability to aid re-
search on cartilage healing or surgical joint replacement
in future studies of osteoarthritis. The use of MRI to
study outcomes [160, 161] points to a non-invasive
measure of disease outcome by replacing the need for
histopathology. Additionally, immunofluorescence on
unfixed cryosections has been used in this model to study
the degenerative changes of OA [158].
Lapine models Analogous to canine models, a subset of
lapine models involve transarticular mechanical impact
on the patellofemoral joint (Fig. 5). A sub-fracture im-
pact is directed toward the rabbit knee leading to
osteoarthritic changes [162–168]. Some of the rabbit
models also included an exercise program to induce
changes in bone remodeling [164]. In addition, some
femoral condyle impact models that utilize a pendulum
swing to replicate knee trauma have been described
[169–172]. However, these femoral condyle impactmodels and the most recent literature involving the
use of a lapine transarticular impact model [173] in
rabbits involve invasive surgery which may lead to several
undesired effects as discussed for induced/invasive models
(in the “Post-traumatic osteoarthritis: non-invasive animal
models” section).
Current outlook on non-invasive animal models
Some of the advantages and disadvantages of invasive
and non-invasive animal models are presented in Table 3.
The results of non-invasive animal models are highly re-
producible. What may give them a greater advantage
over induced models is the precision of the results on
each animal. For example, the IATPF model reported an
87 % success rate in reproducing fractures similar to
clinically evident fractures [142]. Their ability to remove
any artefacts of surgical intervention, such as the profi-
ciency of the surgeon and inflammatory changes or fac-
tors due to the surgery itself (Table 3), makes them
suitable options to study the pathogenesis of osteoarth-
ritis and the possible role of systemic inflammation in
the disease process. They also closely simulate human
injuries leading to PTOA. But even with the possible
benefits of using non-invasive models, there are still lim-
itations to its use. Recent literature have noted the effect
of age, sex (hormonal status), and mouse strain on the
results of this model as possible limitations [174, 175].
However, recording the results using the Animal Re-
search: Reporting of In Vivo Experiments (ARRIVE)
guidelines [176] would improve uniformity and make
the results reproducible. These are a set of strategies de-
signed to give information on how to record the condi-
tions of the experiment and report the results. Another
possible limitation is the need for properly trained
personnel to use these custom modified equipment [4].
These modifications are not universally available, further
Fig. 5 Impact experiments were performed by dropping a mass with a padded impact interface (A) (3.76-MPa crush strength—Hexcel) onto the
patellofemoral joint with 6.6 J of energy. Taken with permission from Ewers et al. [166]
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precision, proper placement of the joints in the equip-
ment is required to reduce variation in the results. Fur-
thermore, the angle of knee flexion may affect the
results of the experiment. These factors may account for
the differing results already seen between similar studies.
For example, in one study by Radin et al. [177] of
patellofemoral loading on rabbits involving an exer-
cise program, microfractures were found in the ar-
ticular cartilage which were not found in a later study
by Newberry et al. [164].
Pain models
Chronic pain and discomfort are the hallmarks of OA.
Thus, the evaluation of chronic pain along with the mo-
lecular pathways leading to OA is an integral part of un-
derstanding the pathogenesis of OA and developing
successful treatment regimen for the disease. However,
unlike the possible molecular pathways leading to OA,
evaluation of chronic pain is highly complex due to the
inherent variability associated with the experiments and
interpretation of the results [178].
Animal models pertinent to understanding the basic
pathogenesis and disease progression of OA have been
established, courtesy of standards such as the Osteoarth-
ritis Research Society International (OARSI) initiatives
for uniformity across the studies. However, till date, no
such standards exist for the study of chronic pain [179].
In addition, animals behave differently when under pain,
depending on the nature of the species. For instance,
rats, mice, and guinea pigs, which are prey animals, tend
to hide their pain as a natural instinct as this would at-
tract predators. However, the same behavior cannot be
said to be true for higher order animals such as dogs
and cats [18]. For instance, when dogs are under distress
they tend to express their pain by not being active, whin-
ing, and licking. Cats on the other hand hiss and hide
the injured or painful site. Thus, movement changes dueto OA in dogs and cats can be better studied than
smaller animals [180]. Despite their marked differences
in behavior when under pain, small animals are widely
used to study OA-related pain. A web of science® search
for small animal models with keywords “Knee Osteo-
arthritis Pain Mice,” “Knee Osteoarthritis Pain Rats,”
“Knee Osteoarthritis Pain Guinea Pigs,” and “Knee
Osteoarthritis Pain Rabbits” showed 117, 415, 40, and 91
articles, respectively. On the contrary, the search on
higher order animals using the keywords “Knee Osteo-
arthritis Pain Dogs,” “Knee Osteoarthritis Pain Cats,”
and “Knee Osteoarthritis Pain Sheep” showed 78, 36,
and 14 articles, respectively. The potential reasons why
higher order animals are not preferred, at least in pre-
liminary investigations, are due to their prohibitive cost,
housing, maintenance, and in some cases, ethical con-
cerns. Although no evidence exists to suggest small
order animals replicate the results in humans, it is still
widely used as illustrated by the web of science® search.
On the contrary, higher order animals are expected to
replicate at least some features, since they are more
similar anatomically and biomechanically [179].
Various subjective models based on mechanical, ther-
mal, anatomical, and chemical changes have been re-
ported for both smaller as well as larger animal models.
OA induced in animals via surgical, chemical, and mech-
anical means are commonly used to evaluate OA related
pain [178]. Some of the most commonly used animal
models (induction methods), species, and outcome mea-
sures are summarized in Table 4. Induction methods fre-
quently employed by chemical means include MIA,
carrageenan, and papain, while, surgically, employed
means include anterior cruciate ligament transection,
medial meniscal transection, and meniscectomy. Of these,
MIA is the most widely reported method (ca. 50 %), and
about 25 % are surgically induced in animals. The extent
of pain in small animals with OA is commonly assessed
by techniques such as the rotarod test, incapacitance test,
Table 4 Commonly used animal models and outcome measures for pain in osteoarthritis
Induction method Species Changes observed/outcome measures
MIA Rat, mouse (knee) Thermal and mechanical analgesia, mechanical sensitivity and changes in the gait [18, 316],
hyperalgesia and allodynia [317], hind limb grip force test [318]
CAR Rat Mechanical allodynia, gait, limited locomotion [319]
Rabbit Hind limb weight distribution, mechanical hyperalgesia [18]
Guinea pig Thermal hyperalgesia [18]
ACLT Rat, rabbit Mechanical allodynia, gait analysis [18, 320]
Dog Gait analysis and altered mobility [321]
MNX Mice Mechanical allodynia, mechanical and thermal sensitivity [322]
MMT Rat Hind paw weight, allodynia [323], mechanical sensitivity [324], decreased paw withdrawal [325]
Sheep Hind paw weight [18]
MIA sodium monoiodoacetate-induced OA, CAR carrageenan-induced OA, ACLT anterior cruciate ligament transection, MNX meniscectomy, MMT medial
meniscal transection
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mal sensitivity, paw withdrawal, and knee extension. For
larger animal models, test methods such as gait analysis
and lameness (by proxy) are most frequently utilized. Vari-
ous pain scales are used in humans and based on the de-
scriptive nature of pain. These include the Simple
Descriptive Scale (SDS), Visual Analog Scale (VAS),
Numerical Rating Scale (NRS), Composite Scale (CS), and
Western Ontario and McMaster Universities Osteoarth-
ritis Index (WOMAC). Unlike humans, VAS-based scor-
ing system may not be feasible with all animal models. But
it would be feasible to use these scales with domesticated
animals such as dogs and cats, whose owners would be
able to understand the cues exhibited by the animals.
Therefore, the owner could stand as a proxy for the ani-
mal [181]. In addition, imaging techniques such as MRI
has been shown to correlate exceptionally well for osteo-
arthritic pain in humans [182, 183].
Miscellaneous models
Although spontaneous models have been used to study
obesity in relation to increased joint loading and osteo-
arthritis development, there are specific joint loading
models used to measure the impact of activity and knee
malalignment on OA development. Race horses have
served as equine models for the study of microstructural
changes in articular cartilage due to overloading of the
joint. These changes have occurred despite a grossly in-
tact hyaline cartilage [184, 185]. Lapine models have
been shown to exhibit degenerative changes in the side
of increased chronic loading in the knee joint, with the
use of a mechanical varus-loading device [186]. A similar
experiment was performed in rats to study gait changes
after medial knee compartment overload [187].
Measures of disease outcome
As mentioned earlier, the two major goals of OA re-
search in animals are to either study the pathology ofthe disease or test the efficacy of treatment. Techniques
such as histopathology, biomarker measurements, im-
aging, pain measurement, and biomechanical assessment
have proven useful to achieve these goals. Typically,
microscopic studies (e.g., histopathology) are done in
smaller animals while more macroscopic studies (such
as MRI) are used in larger animals. But recent advances
in techniques, for instance micro-MRI, have enabled
visualization of critical sections such as bone marrow le-
sions in smaller animals [188]. Their applications in
humans and subsequent use in animal models have
served to improve our understanding of the disease.
Histopathology
Though no one particular standard offers exceptional
correlation to OA, histopathology is currently the gold
standard for assessing of OA in animal models [189].
The histology samples, in conjunction with immunohis-
tochemical staining, can be used to classify and measure
the degree of degeneration in the joint. One of the first
techniques that were used to grade OA was reported by
Collins et al. [190] and Curran et al. [191]. Collins
and co-workers [192–194] in a series of articles reported
the variations in the uptake of 35S and subsequent
chondroitin-sulfate synthesis by cartilage cells in the costal
and articular cartilages of the patella in humans with
different stages of OA. Their observation on articular
cartilage tissues obtained from human cadaver was that
sulfate utilization was higher and commensurate with the
degree of damage to articular cartilage [190]. They further
showed that contrary to the popular belief, damage to the
articular cartilage is not caused by loss of chondrocytes
[193, 195]. In fact, increased activity of sulfate utilization
by chondrocytes in damaged cartilage pointed to active
chondrocytes in those tissues. To further enhance the ap-
plicability of this technique, Collins et al. and several other
research teams [194, 195] used new visualization tech-
nique (auto-radiography) and quantification technique
Kuyinu et al. Journal of Orthopaedic Surgery and Research  (2016) 11:19 Page 14 of 27(radiochemistry). Collins and co-workers [193], in
addition, developed a scoring system based on histological
data to classify the knee based on the level of damage
to the cartilage. The extent of damage in the knee
was classified into four groups: grades 0, I, II, and III
and IV, respectively. The first group, i.e., grade 0, had
smooth cartilage surface with no defects; the second
group, grade I, however, exhibited limited damage to
the superficial zones but did not extend deeply into
the bone. The third group, grade II, illustrated fibrillations
extending into the deep zones, and in the last group
(III and IV), significant loss of cartilage along with
deep exposure of the bare bones. A major drawback
of this system was the specimens were obtained from
either surgical removal of the patella or from necrop-
sies. Hence, neither the pathogenesis of the disease nor
the progression of OA can be studied by this model.
A point-based grading system was subsequently devel-
oped by Mankin et al. [196, 197]. Here, surgically re-
moved human femoral heads were histopathologically
correlated with biochemical changes in DNA and carbo-
hydrate synthesis. The DNA and carbohydrate content
were studied by the incorporation of 3H-thymidine
and 35SO4, respectively. Higher carbohydrate content
correlated with lower disease progression, even though
the same could not be concluded for DNA. From the
experimental observation, a new 14-point grading sys-
tem based on cellular, histochemical, and biomechan-
ical changes was created [198]. This system is known
as the Mankin score system or more commonly
known as Histologic/Histochemical Grading System
(HHGS) [196, 199, 200].
Although the Mankin score and previous grading sys-
tems were extensively used in animal models to study
OA, they present challenges while investigating early or
intermittent stages of OA. Several modified grading sys-
tems such as modified-Mankin or modified-HHGS have
therefore been developed to address the poor reproduci-
bility and intra and inter-observer variations of Mankin
scoring system [198]. At the same time, Mankin scale
can be successfully used to study sodium monoiodoacetate
induced OA due to the rapid progression of the disease to
form terminal OA. Other scoring systems commonly used
in animal models include O’Driscoll, International Cartil-
age Repair Society (ICRS and ICRSII), and modified
O’Driscol scores [189, 201, 202]. A recent study comparing
the various histological scoring systems for OA showed
that the ICRSII, O’Driscoll, and modified O’Driscoll scores
had higher reliability than other histopathological scores,
including the Mankin score [203].
To enhance reproducibility, decrease intra- and inter-
observer variations, and standardize the assessment and
reporting techniques across animal models, the OARSI
formed a working group in 2010 to develop a standardOA grading system [54]. The five cardinal principles
the working committee used to determine ideal OA histo-
pathological system were simplicity, utility, scalability, ex-
tendibility, and comparability [204]. The OARSI working
group’s recommendation aimed to address some of
the deficiencies observed in preclinical studies such
as lack of defining clear distinction of OA subsets,
established clinical trial endpoints, evaluation of bio-
markers, histopathology, and exclusion of other arth-
ritis types.
Some of the remarkable progress made by this commit-
tee were established clinical trial end points, defined sub-
sets of OA and guidelines to evaluate new features of OA
(apart from cartilage) and evaluate histopathology in ani-
mal models. Based on the severity of OA, the working
group classified OA into seven grades with grade 0 being
uninvolved or intact cartilage and grade 6 involving de-
formation of articular contour. Unlike the older scoring
techniques, the OARSI technique specifically relied on the
depth of progression into the cartilage to grade OA. By
borrowing concepts from cancer pathology, efforts were
also made to designate the severity of OA lesions by stages
[16]. The OARSI working group provides this information
through a released set of guidelines for each animal used
in animal models [51, 54, 205–211].
Imaging modalities
Imaging modalities frequently used to investigate OA in
humans include x-rays, MRI, μ-CT scans, and ultra-
sound. Traditionally, OA is evaluated with radiographs
in the clinic to demonstrate joint space width (JSW) and
the formation of osteophytes [212]. Radiographs also
permit the visualization of subchondral sclerosis and
subchondral cysts [213]. Various animal models with rats
[214], rabbits [215], and dogs [216] have been studied
using radiography including the most famous Pond-Nuki
model (dogs) [217]. In rats and rabbits, radiography has
been used to study subchondral bone remodeling and
joint space narrowing. Recent research, however, suggests
cartilage loss alone is not the sole contributor to OA, but
changes in the morphology of menisci also play an equally
responsible role [218–221]. Unfortunately, radiography,
which is the current gold standard for imaging OA, lacks
sensitivity to visualize such variations [222]. Moreover,
changes in the flexed position used in the follow-up
imaging also might lead to conflicting conclusions,
which severely restricts the application of radiography
in OA [223]. In addition, radiography allows only late
stage visualization of OA and does not allow direct
visualization of cartilage itself. To some degree, utilizing
computer tomography (CT) arthroscopy circumvents this
problem. Unfortunately, this technique is invasive [224].
Despite these disadvantages, radiography is still widely
used in the clinical setting. Various grading schemes
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WOMAC, Knee Injury and Osteoarthritis Outcome Score
(KOOS), and VAS have been developed over the years and
are widely used [225–228].
Magnetic resonance imaging (MRI), unlike radiog-
raphy, is capable of visualizing not only the cartilage but
also the menisci, ligaments, synovium, and biochemical
markers pertaining to OA [229]. By virtue of its ability
to phase contrast tissues, it can distinguish and study in-
dividual tissues. Despite its high cost, due to its potential
and capabilities, MRI is a fast advancing tool replacing
radiography in characterizing and detecting early stages
of OA [33, 230, 231]. For high resolution imaging, a
minimum of 1 Tesla (T) scanners are typically required.
Currently, the most widely used models in clinics are
the 1.5-T scanners. But recently, the 3-T model has been
introduced and is fast becoming the choice for imaging
[232]. Higher field strength scanners (7 T) are currently
under development [233] and are expected to result inTable 5 Examples of various MRI techniques used in OA animal mo
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Sodium MRI Porcine (intra-articular injection (IL-
1beta)
Prot
Magnetization transfer Rat model (antigen induced) Mac
Goat knee-papain Colla
Rabbit-medial meniscectomy Colla
T1-rho T1 in the rotating frame, ACLT anterior cruciate ligament transection, dGEMR
IL interleukinhigher signal to noise ratios, albeit with minor issues
such as chemical shifts.
Application of utilizing these MRI techniques in ani-
mal models is summarized in Table 5. With significant
advancements in instruments and hardware and with its
superior capability, MRI, unlike radiography, is expected to
take a leading role in future animal model experiments to
study various aspects of OA [234]. The difficulty in utiliz-
ing radiology has prompted the development of these alter-
nate techniques to study OA in animals. Till date, MRI has
been utilized to study various animal models, small and
large, including rat, rabbit, guinea pig, dog, and non-
human primates (rhesus macaque) [234–240]. For ex-
ample, in rat osteoarthritis models, several osteoarthritic
changes can be monitored in vivo with the use of MRI
[241–243]. In rabbit models, cartilage thinning and swell-
ing, decrease in proteoglycan content, and mild subchon-
dral changes can be observed which are typically difficult
to visualize using radiography [244]. MRI has also beendels
ubset studied
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ophytosis and synovial thickening [329]
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IC delayed gadolinium-enhanced magnetic resonance, OA osteoarthritis,
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naturally occurring OA caused by obesity in the guinea pig
model [245]. Some surgical models which induce OA and
have used MRI to study changes include ACLT and Medial
Meniscus Tear [244, 246]. In much smaller animal models
such as mice, standard MRI measurements are not pos-
sible; however, micro-MRI has been utilized to study ACLT
induced OA [247] and in Brtlmouse models [248].
Cartilage is essentially composed of collagen, proteo-
glycans, and water [26]. All three components play a
complex role in the functioning of the tissue. Any
change in their composition causes debilitating effect on
the tissue and ultimately leads to OA. That is another
reason why radiography ultimately fails in its ability to
study OA. Site-specific studies can be fortunately per-
formed, unlike in radiography, by MRI using various tech-
niques such as gradient recalled echo (GRE), spin echo
(SE), fast SE, and 3D SE, which have profound impact in
studying the morphological changes of the cartilage dur-
ing OA [249]. To enhance the physiological imaging, tech-
niques such as T1 and T2 relaxometry [250], chemical
exchange saturation transfer (CEST) [251], magnetization
transfer (MT) [252], sodium MRI [253], diffusion-
weighted imaging (DWI) [254], digital tensor imaging
(DTI) [255], and, more recently, delayed gadolinium-
enhanced magnetic resonance (dGEMRIC) [256] imaging
of cartilage have been used to visually observe the glycos-
aminoglycan (GAG) component of cartilage (Table 5).
For instance, T1 in the rotating frame (T1-rho) works
by measuring the spin-lattice relaxation in the rotating
frame, and any loss of aggrecan can be measured indir-
ectly by observing the motion of water molecules [257].
T1-rho has been reported to be used for studying cartil-
age degeneration, decrease in cartilage thickness, loss of
proteoglycans, and changes in synovium (Table 5). On
the other hand, in T2 mapping, an increase in relaxation
times indicates the inefficiency of water molecules to ex-
change the energy inside the matrix [258]. Some of the
features of OA that are typically studied, as summarized
in Table 5, using T2 mapping include synovitis, macro-
phages, collagen order, sclerosis, and proteoglycan loss.
Combining one of the techniques with dGEMRIC en-
sures GAG content can also be estimated. An added ad-
vantage with this technique is that it is reproducible, and
statistical difference in specimen can be observed in as
little as 10 weeks [259].
Typically, the most imaging modalities for OA involve
characterizing proteoglycans, but some techniques such
as DWI and DTI work by studying the orientation as
well as the flow of water molecules through the cartilage.
In DWI when diffusion sensitizing agents are applied,
water molecules possess a random directionality with a
uniform signal intensity. However, when it encounters a
diffusion, it undergoes a signal drop, which indicatesunhealthy cartilage [260]. DTI, which is an advanced im-
aging technique, is capable of measuring not only diffu-
sion of water but also the direction of the flow which
aids in mapping the cartilage tissue [261]. MRI, similar
to nuclear magnetic resonance (NMR) spectroscopy,
works based on the fact that any atom with odd number
of protons with non-zero spin would exhibit magnetic
resonance phenomenon [262]. In that aspect, 23Na can
also be used instead of conventionally used 1H to image
cartilage and other relevant tissues. When 23Na atoms
bind with the negatively charged GAG chains in the car-
tilage, any loss of GAG results in diminished Na ions,
which indicates loss of cartilage due to OA [263]. Des-
pite its high potential to study the cartilage, using 23Na
requires specialized coils which inhibit their clinical use.
Their far lower Larmor frequency and concentration at
resonance frequency (signal strength) compared with 1H
further dampens its case to be used for MRI imaging
[264]. But with significant improvements in instrument
hardware, it can be envisaged that 23Na would be a tool
of interest in the near future to detect early stages of
cartilage changes with OA. Study of loss of proteoglycan
is typically studied using this MRI imaging technique
(Table 5).
Apart from the loss of proteoglycans as described by
Collins et al., it has been reported that synovitis, the in-
flammation to the synovial fluid, also plays a key role in
the early stages of OA [31]. Plain radiography is incap-
able of imaging synovial fluid and is thus not used for
this purpose. Ultrasound and MRI are the most com-
monly used modalities to image synovitis. Non-contrast-
enhanced (CE) and gadolinium (Gd)-based CE-MRI are
two techniques commonly used to observe synovitis
[265, 266]. In addition, 2D spin echo and 3D gradient
echo are the other two techniques employed to study
synovitis. Aside from synovitis, these techniques can de-
tect intraosseous cysts; lesions in the meniscus, bone,
and ACL; and subchondral bone defects and can also
map articular synovial space. Ultrasound has found some
success in animals and humans to detect other early
osteoarthritic changes [33, 267]. The ultrasound serves
as a quicker and cost effective method to study out-
comes in animals (Table 5).
The OARSI currently recommends MRI for morpho-
logic evaluation in humans and also for use in preclinical
trials [16, 33, 230]. An added advantage in using MRI is
its simplicity in developing a grading system which facil-
itates uniformity, comparability, and reproducibility
across various models. Since MRI is fast emerging as a
tool for imaging OA in humans, it is expected to play a
key role in studying OA in animal models. Some of the
grading systems that are commonly used with MRI in-
clude Whole-Organ Magnetic Resonance Imaging Score
(WORMS), Boston-Leeds OA Knee Score (BLOKS), and
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MOAKS being the most widely used scoring systems in
MRI based modalities [268–271].
μ-CT is another powerful technique utilized to study
3D structures reconstructed from slices of 2D images
[212]. It is widely used to study bone formation, healing,
and remodeling. However, as with radiography, CT even
with multisource spiral CT scanners is yet to find any
significant application in visualizing OA (knee), espe-
cially in its initial stages [272]. With that said, although
its application might be restricted for knee OA, it has
huge potential for hip and TMJ OA [273]. However, as
mentioned before, it could be an excellent tool to
visualize changes in the bone joints, and MRI with its
significant advantages can easily replace CT for knee
OA. A more invasive version of CT, optical coherence
tomography, is frequently used to study the diseased
state of cartilage by affixing with an arthroscope. Also,
by combining with other techniques such as MRI and
positron emission tomography, CT is expected to
make significant contribution in studying early stages
of OA [274]. In addition, by utilizing contrast agents,
contrast resolution of the cartilage images can be en-
hanced. Recently, μ-CT has been utilized to image
subchondral changes and thus follow progression of
OA in rats and mice [275]. In rat and mice models,
for instance, collagenase-induced subchondral changes
and cortical bone loss have been reported using μ-CT
technology [276, 277].
Positron emission tomography (PET) is a unique
technique used primarily in oncology, cardiology, and
neuroscience [278]. It allows measurement of func-
tioning of tissues by using compounds that are short-
lived positron emitting nuclides [279]. A widely used
positron emission (PE) nuclide is fluorine-18 fluoro-
deoxyglucose (18F-FDG) [280, 281]. Typically, it is
used to detect glucose uptake by cells, and fortu-
nately, it can also be utilized for OA as glucose up-
take take place in cartilage by proteoglycans. Apart
from OA, PET has potential to investigate chondro-
sarcomas and tumors in the bone [282, 283]. Re-
cently, 18F-FDG based PET was utilized in a rat
model to investigate the early stages of OA. This
study indicated its significant potential to detect OA
within 2 weeks of induction, while, in histology, a
minimum of 8 weeks was required [284]. Even though
PET was not extensively used for OA evaluation pre-
viously, it is rapidly finding niches in investigating
OA in conjunction with other techniques such as CT
and MRI.
In addition to the currently used imagining studies,
FRI has shown success in non-invasive mouse models to
quantify the biological responses and time course in OA
[141]. In a recent study, bioluminescence has also shownpromise in mouse models of osteoarthritis to measure
cartilage changes [285]. For this study, chondrocyte mu-
tation in the CreERT2 protein, which is activated by tam-
oxifen injection, was successfully applied to mice
undergoing joint destabilization studies and treadmill
exercises. The technique might well prove useful as a
non-invasive imaging modality for future studies of car-
tilage degeneration.
Biomarkers
Biomarkers of cell degeneration and inflammation
can serve as a measure of disease progress or treat-
ment outcomes in clinical osteoarthritis. These mole-
cules are precursors or products of metabolism
released in the serum, urine, and synovial fluid, and
their levels correlate with osteoarthritic changes in
the joint. The Burden of Disease, Investigative, Prog-
nostic, Efficacy of Intervention and Diagnostic
(BIPED) classification [286] has been applied to
these biomarkers to develop and analyze their effect-
iveness in OA research. Several biomarkers are com-
mercially available for use in clinical trials [6, 33,
287, 288]. Well-published biomarkers are urinary C-
telopeptide of type II collagen (CTX-II) and serum
cartilage oligomeric matrix protein (COMP) [289,
290]. Other clinical biomarkers include serum hya-
luronic acid (HA), serum and urine Coll2-1 (a pep-
tide of the alpha-helical region of type II collagen)
and its nitrated form Coll2-1 NO2, and YKL-40 (also
known as chitinase 3-like 1, CHI3L1, or cartilage
glycoprotein-39) [291–294]. Despite their availability,
further investigation into the applicability of these
markers in clinical research is needed due to the lack
of consistency in results of its application [288]. Re-
search is ongoing to evaluate new biomarkers for pre-
clinical and clinical studies. In animal models of
osteoarthritis, this research also assesses the useful-
ness of biomarkers in studying early osteoarthritic
changes and the effect of treatment.
In an STR/ort mouse model of primary OA, MMP-3
was found to be a sensitive biomarker to detect early
OA changes [295]. A novel COMP enzyme-linked im-
munosorbent assay (ELISA) was used to study COMP
fragments as a biomarker of OA in the serum of induced
mice models. This was found to correlate with results in
humans using this assay [296]. Serum xylosyltransferase
1 (Xylt1) is increased in mice models of OA under a
background of mice with high bone forming potential.
This study suggests an application of this marker in
studying OA risk in young adults [297]. There have also
been promising results in the application of biomarker
research in other small animal models. In rats, this was
accomplished using immunohistochemical staining of
histological sections [298]. The MIA model has been
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age degradation, using aggrecan neoepitope release in
synovial fluid to follow these changes [299]. The rat
MIA model has also been used to test meloxicam as a
treatment for OA and the ability of the drug to reduce
the biomarker CTX-II [300]. CTX-II has been associated
with cartilage changes in conjunction with differences in
animal age in a rabbit-ACLT model [301, 302]. Rabbit
models of ACLT have shown a similar correlation of the
biomarkers HA and chondroitin-sulfate 846 epitope,
with the severity of OA in the joint [303]. Guinea pigs
have been assessed to determine the usefulness of bio-
markers in spontaneous models [97].
In recent years, several biomarker research studies
have involved the use of dog models. Dogs share the
same MMPs as humans and biomarker research can
be translated better to clinical studies [304]. In a ca-
nine model of ACLT, serum levels of CTX-II were el-
evated indicating that this model is sensitive and
specific for early articular changes in OA [305].
Serum levels of fetuin B and complement C3 were
also elevated in this surgical model in another study
[306]. Garner et al. on a surgically induced canine
model showed an increase in monocyte chemoattract-
ant protein-1 (MCP-1) and IL-8 in the synovial fluid
[307]. Another study by Alam et al. utilizing a surgi-
cal canine model showed a correlation between dis-
ease progression and the serum or synovial fluid
levels of tartrate resistant acid phosphatase (TRAP),
matrix metalloproteinase-2 (MMP-2), and tissue in-
hibitor of matrix metalloproteinase-2 (TIMP-2) [308].
These substances could serve as possible biomarkers
to study early OA changes in other animal models
and humans. Tenascin-C is another biomarker found
in both canine and human synovial fluid during
osteoarthritic changes, and this substance could play
an additional role in increasing joint degradation
[309]. Finally, Coll2-1 and Coll2-1 NO2 as biomarkers
were also found to correlate with OA changes in the
canine ACLT model [310].
Regrettably, no gold standard exists in the literature for
animal studies and translation from in vitro to in vivo
studies, then clinical studies, has met with difficulties
[311]. In animal studies, biomarkers are most useful when
taken directly from the joint synovial fluid [16]. Yet, this is
not always feasible in the smaller joints of small animal
models such as mice; aspirated samples from these studies
would be insufficient. Although biomarkers could be mea-
sured from other sources, such as urine samples, their
levels are influenced by other diseases or metabolic condi-
tions just as in clinical studies. Therefore, more bio-
markers have been developed for animals with larger
joints such as guinea pigs and dogs [97, 307]. Other ani-
mals utilizing biomarkers are sheep and horses [312, 313].Used in conjunction with imaging studies, biomarkers can
give a greater characterization of the disease process in
both large animal models and humans [33, 312, 314].
Concluding remarks
Each osteoarthritic model, which can also be used in
combination with other models, has proven useful in im-
proving our understanding of OA. The disease has been
shown to develop through an inflammatory mechanism.
Several small and large animal models have been devel-
oped to make these findings, and these models can be
related to the disease etiology. Subsequently, the drugs
or treatment methods tested in animal models could
provide abundant benefits to human subjects with the
disease. Yet, there is a shortage of literature on specific
translational effects of these animal models and their re-
lationship to human clinical outcomes of tested drugs.
Although it is well known that the efficacy of treatment
in preclinical models do not always translate to the hu-
man condition, translational data providing this informa-
tion would help in developing improved animal models.
There is also a limited amount of literature on other ani-
mals such as mini-pigs or cows [16]. Although these
models could potentially not be as anatomically relevant
or well-studied, their abundancy ensures availability for
studies. An investigation into the disease process in
these animals with non-invasive models has the potential
to be relevant to OA studies.
Non-invasive animal models are great alternatives for the
study of OA in mice, dogs, rabbits, and possibly rats. But
there is a dearth of literature on non-invasive models for
larger animals. These would be needed as there is a great
potential of these models to improve OA studies. They are
reliable tools for studying early OA changes that would not
be possible in invasive (induced models). Several benefits
of mimicking the human OA condition have been found.
However, it still mimics just PTOA. Although our depth of
knowledge of OA could improve with the development of
less invasive studies that mimic POA, the closest model to
accomplish this goal is the CACTC model. This model
simulates chronic joint overuse. In contrast, spontaneous
models will remain the best possible models to study POA
until an alternative can be found. There are also some
problems with uniformity in the results across studies.
Although the OARSI provides guidelines in animal OA re-
search, as of the writing this paper, there are no guidelines
to address non-invasive animal models.
The successful use of ultrasound and MRI, as well as
the increasing usefulness of PET, in both humans and
animals would significantly improve studies of OA.
These imaging studies are emerging as important non-
invasive alternatives to histopathology in animal models
and would allow for disease observation in vivo. How-
ever, there is a need for standardization of these
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tain uniformity and ease of comparison across all
studies.
Despite the innovations in OA research, results of pre-
clinical treatment studies have shown poor translation to
clinical trials. A possible reason is most studies involve
PTOA, but the generated therapeutic intervention is
used to treat POA. PTOA accounts for just 12 % of
symptomatic OA [315], and its pathophysiology is dis-
tinct from POA [17, 21]. Hence, these treatment tech-
niques would be inappropriate in treating POA.
Another problem with animal model experiments lies
with data collection in these studies. Certain important
factors, such as animal husbandry conditions and the sex
of the animal, have been excluded from the results but
may show a great effect on the outcomes [16]. The AR-
RIVE guidelines mentioned earlier (section “Current out-
look on non-invasive animal models”) serve to address
this discrepancy [176]Conclusions
This review presents an overview of animal models cur-
rently used to study the pathogenic changes in OA along
with the resulting symptoms and the effect of treatment
on the disease. New models are being designed to study
more aspects of the disease. Nevertheless, additional ex-
ploration would still be needed by the researcher in de-
termining the best model and expected outcomes for
their study. These include the cost, housing, type of ani-
mal, and length of experiment which should be further
investigated to make the best possible choice for their
study.
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